Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA moves toward easing restrictions on certain peptides BioPharma Dive How did BPC 157 become the wellness industry's star peptide? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Is BPC 157 Banned? Oral vs. Injectable Forms Explained